Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: tnsaf who wrote (1550)	3/18/2002 7:40:08 PM
From: tuck	Respond to of 1728

Profile of the new U133 set: >>Santa Clara, Calif.-based Affymetrix's new GeneChip® Human Genome U133 set is the first commercially available microarray set designed using the April 2001 draft of the human genome. Affymetrix incorporated 2.7 million source sequences in the array's design; the final product includes 45,000 probes in a two-array set representing 39,000 transcripts from 33,000 well-substantiated genes. "Each of the arrays in the set has over 500,000 individual oligonucleotide features," says marketing director Elizabeth Kerr. "That's huge, and it's something nobody else can do," she says.<< The rest here: the-scientist.com Cheers, Tuck